Severe corneal melting after cataract surgery in patients prescribed topical postoperative NSAIDs and dexamethasone/neomycin combination therapy.
Administration, Ophthalmic
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal
/ adverse effects
Cataract Extraction
/ adverse effects
Corneal Diseases
/ chemically induced
Drug Combinations
Female
Fluprednisolone
/ adverse effects
Humans
Ketorolac
/ adverse effects
Male
Neomycin
/ adverse effects
Ophthalmic Solutions
Polymyxin B
/ adverse effects
Prescription Drugs
Retrospective Studies
Visual Acuity
/ physiology
Journal
Journal of cataract and refractive surgery
ISSN: 1873-4502
Titre abrégé: J Cataract Refract Surg
Pays: United States
ID NLM: 8604171
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
entrez:
13
2
2020
pubmed:
13
2
2020
medline:
7
2
2021
Statut:
ppublish
Résumé
Three patients using a postoperative combination of topical ketorolac (Acular) and neomycin/polymyxin B sulfate/dexamethasone (Maxitrol) were diagnosed with atypical keratopathy soon after routine cataract surgery. An immediate retrospective analysis of hospital patients who had used this topical drug combination in the previous year identified 10 other patients who also had significant corneal pathology after uneventful cataract surgery. Five of the 13 affected patients had corneal melting and 1 patient had corneal perforation and endophthalmitis. At the last recorded follow-up appointment, 8 of the 13 patients had a visual acuity of 6/36 or worse. Corneal melting is a rare complication of topical nonsteroidal anti-inflammatory drugs (NSAIDs). We propose that the combined use of topical NSAIDs and other agents, such as neomycin and benzalkonium, that further compromise the corneal epithelium, should be used with vigilance and increased awareness of potential keratopathy and permanent visual morbidity.
Identifiants
pubmed: 32050243
doi: 10.1016/j.jcrs.2019.08.033
pii: 02158034-202001000-00020
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Drug Combinations
0
Ophthalmic Solutions
0
Prescription Drugs
0
Maxitrol
78666-15-6
Fluprednisolone
9H05937G3X
Neomycin
I16QD7X297
Polymyxin B
J2VZ07J96K
Ketorolac
YZI5105V0L
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM